Nasal Microbiota and Infectious Complications After Elective Surgical Procedures.
Aged
Bacteremia
/ epidemiology
Cardiac Surgical Procedures
Case-Control Studies
Craniotomy
Elective Surgical Procedures
Female
Humans
Male
Microbiota
Middle Aged
Nose
/ microbiology
Pneumonia
/ epidemiology
Postoperative Complications
/ epidemiology
RNA, Ribosomal, 16S
Risk Assessment
Risk Factors
Spinal Fusion
Staphylococcus aureus
Surgical Wound Infection
/ epidemiology
Vascular Surgical Procedures
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 04 2021
01 04 2021
Historique:
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
25
8
2021
Statut:
epublish
Résumé
The association of the nasal microbiome with outcomes in surgical patients is poorly understood. To characterize the composition of nasal microbiota in patients undergoing clean elective surgical procedures and to examine the association between characteristics of preoperative nasal microbiota and occurrence of postoperative infection. Using a nested matched case-control design, 53 individuals who developed postoperative infection were matched (approximately 3:1 by age, sex, and surgical procedure) with 144 individuals who were not infected (ie, the control group). The 2 groups were selected from a prospective cohort of patients undergoing surgical procedures at 2 tertiary care university hospitals in Baltimore, Maryland, who were at high risk for postoperative infectious complications. Included individuals were aged 40 years or older; had no history of autoimmune disease, immunocompromised state, immune-modulating medication, or active infection; and were scheduled to undergo elective cardiac, vascular, spinal, or intracranial surgical procedure. Data were analyzed from October 2015 through September 2020. Nasal microbiome cluster class served as the main exposure. An unsupervised clustering method (ie, grades of membership modeling) was used to classify nasal microbial samples into 2 groups based on features derived from 16S ribosomal RNA gene sequencing. The microbiome cluster groups were derived independently and agnostic of baseline clinical characteristics and infection status. Composite of surgical site infection, bacteremia, and pneumonia occurring within 6 months after surgical procedure. Among 197 participants (mean [SD] age, 64.1 [10.6] years; 63 [37.7%] women), 553 bacterial taxa were identified from preoperative nasal swab samples. A 2-cluster model (with 167 patients in cluster 1 and 30 patients in cluster 2) accounted for the largest proportion of variance in microbial profiles using grades of membership modeling and was most parsimonious. After adjusting for potential confounders, the probability of assignment to cluster 2 was associated with 6-fold higher odds of infection after surgical procedure (odds ratio [OR], 6.18; 95% CI, 3.33-11.7; P < .001) independent of baseline clinical characteristics, including nasal carriage of Staphylococcus aureus. Intrasample (ie, α) diversity was inversely associated with infectious outcome in both clusters (OR, 0.57; 95% CI, 0.42-0.75; P < .001); however, probability of assignment to cluster 2 was associated with higher odds of infection independent of α diversity (OR, 4.61; 95% CI, 2.78-7.86; P < .001). These findings suggest that the nasal microbiome was an independent risk factor associated with infectious outcomes among individuals who underwent elective surgical procedures and may serve as a biomarker associated with infection susceptibility in this population.
Identifiants
pubmed: 33914049
pii: 2779303
doi: 10.1001/jamanetworkopen.2021.8386
pmc: PMC8085724
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e218386Subventions
Organisme : NIAID NIH HHS
ID : U19 AI110820
Pays : United States
Références
PLoS One. 2012;7(8):e43052
pubmed: 22905200
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
J Hosp Infect. 2010 Jul;75(3):153-7
pubmed: 20434794
Sci Transl Med. 2012 Sep 12;4(151):151ra124
pubmed: 22972842
Sci Transl Med. 2012 Jun 6;4(137):137rv7
pubmed: 22674557
mSphere. 2017 Sep 13;2(5):
pubmed: 28932812
Appl Environ Microbiol. 2018 May 17;84(11):
pubmed: 29625975
mSystems. 2019 Feb 19;4(1):
pubmed: 30801027
N Engl J Med. 2020 Feb 27;382(9):822-834
pubmed: 32101664
Nature. 2014 May 15;509(7500):357-60
pubmed: 24739969
Ann Surg. 2013 Jan;257(1):150-4
pubmed: 22634899
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
PLoS Genet. 2017 Mar 23;13(3):e1006599
pubmed: 28333934
Sci Transl Med. 2012 May 2;4(132):132ra52
pubmed: 22553250
PLoS Comput Biol. 2013;9(1):e1002863
pubmed: 23326225
Am J Infect Control. 2013 Dec;41(12):1236-40
pubmed: 23890377
Clin Infect Dis. 2009 Jul 1;49(1):124-31
pubmed: 19480579
Am J Med. 1996 May;100(5):509-16
pubmed: 8644762
PLoS One. 2017 Dec 7;12(12):e0188461
pubmed: 29216202
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
N Engl J Med. 2010 Jan 7;362(1):9-17
pubmed: 20054045
Microbiome. 2014 Feb 24;2(1):6
pubmed: 24558975
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Sci Rep. 2018 Jul 30;8(1):11411
pubmed: 30061588
Nat Methods. 2013 Dec;10(12):1200-2
pubmed: 24076764
N Engl J Med. 2002 Jun 13;346(24):1871-7
pubmed: 12063371
J Hosp Infect. 1995 Sep;31(1):13-24
pubmed: 7499817
Sci Adv. 2015 Jun 05;1(5):e1400216
pubmed: 26601194
Clin Microbiol Rev. 1997 Jul;10(3):505-20
pubmed: 9227864
FEMS Microbiol Rev. 2013 Jul;37(4):520-53
pubmed: 23030831
Am J Infect Control. 2004 Dec;32(8):470-85
pubmed: 15573054